-
Expert Consensus on a Definition for Children With Medical Complexity in England: A Modified Delphi Panel
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Perioperative Pembrolizumab for Early Stage Non-Small Cell Lung Cancer (NSCLC) in Greece
Sep 9, 2025, 16:22 PM -
Prediabetes Prevalence and Progression in the UAE: Insights for Early Intervention and Resource Optimization
Sep 9, 2025, 16:22 PM -
Estimating the Clinical and Economic Value of Aztreonam-Avibactam for the Treatment of Metallo-Beta-Lactamase–Producing Carbapenem- Resistant Enterobacterales Infections in China: Adopting the STEDI Value Framework
Sep 9, 2025, 16:22 PM -
Delayed Access to Diabetes Technology in Children With Migration Background: A Cross-Sectional Study on Treatment Equity in Austria
Sep 9, 2025, 16:22 PM -
Optimizing MASLD Follow-up Strategies Under Adherence Uncertainty: A Game Theory and Signaling Approach
Sep 9, 2025, 16:22 PM -
A Real-World Study of Healthcare Resource Utilization (HCRU) and Associated Healthcare Costs for Patients With Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC) in Taiwan
Sep 9, 2025, 16:22 PM -
Integrating Patient-Reported Outcome Measures and Patient Experience Into Health Technology Assessment: A Path Towards Patient-Centered Decision Making
Sep 9, 2025, 16:22 PM -
Overall Treatment Landscape of Mucosal Melanoma
Sep 9, 2025, 16:22 PM -
Real-World Socioeconomic Burden and Health-Related Quality of Life (HRQoL) for Patients Living with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in the UK: Results From an Online Patient Survey
Sep 9, 2025, 16:22 PM -
Assessment of Real-World Effectiveness of Biologic Treatments for Moderate-to-Severe Atopic Dermatitis in Poland
Sep 9, 2025, 16:22 PM -
ROBERTA on the Job: A Proof-of-Concept Study of a Customized GPT Tool for Risk-of-Bias Assessment of Randomized Clinical Trials
Sep 9, 2025, 16:22 PM -
Adapting to Change: Analysis of Trend Estimation in AMNOG Dossiers Under Revised GBA Guidelines
Sep 9, 2025, 16:22 PM -
A Health Economic Evaluation Framework for Implementing a Digital Survivorship Passport for Childhood Cancer Survivors
Sep 9, 2025, 16:22 PM -
Analysis and Characterization of Variations in Conceptual and Operational Definitions for GLP-1 Agonist Treatment Eligibility for Weight Management
Sep 9, 2025, 16:22 PM -
Variations in Screening and Medication Takeup Rates for Alzheimer’s Disease
Sep 9, 2025, 16:22 PM -
A Budget Impact Analysis of Switching From Von Willebrand Factor/Factor VIII Plasma-Derived Concentrate With 2.4-1 Ratio to the Concentrate With 1-1 Ratio for the Management of Von Willebrand Disease in Qatar
Sep 9, 2025, 16:22 PM -
Economic Evaluation of a Standardized Care Pathway for Nontraumatic Acute Abdominal Pain in the Emergency Department
Sep 9, 2025, 16:22 PM -
Factors Associated With the Publication of Real-World Evidence Studies in Lung Cancer by Journal Impact Factor
Sep 9, 2025, 16:22 PM -
Mapping Access Pathways for New Medicines in Finland: A Real-World Review of HTA and Reimbursement Decisions
Sep 9, 2025, 16:22 PM
